These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3192385)

  • 1. Phase I--preliminary phase II trial of iproplatin, a cisplatin analogue.
    Paolozzi FP; Gaver R; Poiesz BJ; Louie A; DiFino S; Comis RL; Newman N; Ginsberg S
    Invest New Drugs; 1988 Sep; 6(3):199-206. PubMed ID: 3192385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of iproplatin in advanced ovarian carcinoma.
    Sessa C; Vermorken J; Renard J; Kaye S; Smith D; ten Bokkel Huinink W; Cavalli F; Pinedo H
    J Clin Oncol; 1988 Jan; 6(1):98-105. PubMed ID: 3335895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of weekly-administered iproplatin [cis-dichloro-trans-dihydroxy-bis-isopropylamine platin (chip, JM9)].
    Chawla SP; Yap BS; Tenney DM; Bodey GP; Benjamin RS
    Invest New Drugs; 1988 Dec; 6(4):311-7. PubMed ID: 3229943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of iproplatin (CHIP) in previously treated advanced breast cancer.
    Meisner DJ; Ginsberg S; Ditch A; Louie A; Newman N; Comis R; Poiesz B
    Am J Clin Oncol; 1989 Apr; 12(2):129-31. PubMed ID: 2705402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of iproplatin (CHIP, JM-9) in advanced testicular cancers progressing after prior chemotherapy.
    Clavel M; Monfardini S; Gundersen S; Kaye S; Siegenthaler P; Renard J; van Glabbeke M; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1345-8. PubMed ID: 3181255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
    McGuire WP; Arseneau J; Blessing JA; DiSaia PJ; Hatch KD; Given FT; Teng NN; Creasman WT
    J Clin Oncol; 1989 Oct; 7(10):1462-8. PubMed ID: 2674333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer.
    de Wit R; Tesselaar M; Kok TC; Seynaeve C; Rodenburg CJ; Verweij J; Helle PA; Stoter G
    Eur J Cancer; 1991; 27(11):1383-5. PubMed ID: 1835851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data Center.
    Vermorken JB; Gundersen S; Clavel M; Smyth JF; Dodion P; Renard J; Kaye SB
    Ann Oncol; 1993 Apr; 4(4):303-6. PubMed ID: 8518220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.
    Hubbard KP; Pazdur R; Ajani JA; Braud E; Blaustein A; King M; Llenado-Lee M; Winn R; Levin B; Abbruzzese JL
    Am J Clin Oncol; 1992 Dec; 15(6):524-7. PubMed ID: 1449117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
    Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinoma.
    Murphy D; Lind MJ; Prendiville J; Renninson J; Smith DR; Thompson G; Ranson M; Crowther D
    Eur J Cancer; 1992; 28A(4-5):870-2. PubMed ID: 1524912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of iproplatin in metastatic breast carcinoma.
    Hortobagyi GN; Frye D; Holmes FA; Hug V; Fraschini G; Buzdar AU
    Cancer Treat Rep; 1987 Dec; 71(12):1193-6. PubMed ID: 3690529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical development of iproplatin (CHIP).
    Creaven PJ; Pendyala L; Madajewicz S
    Drugs Exp Clin Res; 1986; 12(1-3):287-92. PubMed ID: 3732051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of carboplatin given on a five-day intravenous schedule.
    Rozencweig M; Nicaise C; Beer M; Crespeigne N; Van Rijmenant M; Lenaz L; Kenis Y
    J Clin Oncol; 1983 Oct; 1(10):621-6. PubMed ID: 6366128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of iproplatin (CHIP, JM-9) in advanced squamous cell carcinoma of the head and neck.
    Abele R; Clavel M; Monfardini S; Bruntsch U; Renard J; van Glabbeke M; Pinedo HM
    Eur J Cancer Clin Oncol; 1987 Apr; 23(4):387-9. PubMed ID: 3609103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation study.
    Gore ME; Calvert AH; Smith LE
    Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1391-7. PubMed ID: 2824209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG).
    van Glabbeke M; Renard J; Pinedo HM; Cavalli F; Vermorken J; Sessa C; Abele R; Clavel M; Monfardini S
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):255-62. PubMed ID: 3281842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I clinical and pharmacologic trial of carboplatin daily for 5 days.
    Van Echo DA; Egorin MJ; Whitacre MY; Olman EA; Aisner J
    Cancer Treat Rep; 1984 Sep; 68(9):1103-14. PubMed ID: 6383605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.